Atlas Trials

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Clinical trial NCT00245102 · COMPLETED

Trial details

NCT number
NCT00245102
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adult AngiosarcomaAdult Epithelioid SarcomaAdult LeiomyosarcomaAdult Malignant Fibrous HistiocytomaAdult NeurofibrosarcomaAdult Synovial SarcomaOvarian SarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Uterine SarcomaStage III Adult Soft Tissue SarcomaStage III Uterine SarcomaStage IV Adult Soft Tissue Sarcoma
Start date
2005-09-01
Primary completion
2011-03-01
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.